Authors
Latest:
Kind of a Big Deal: Data Utilization in Specialty PharmacyThe pharmaceutical industry cherishes the diverse sets of feedback generated among parties operating in specialty pharmacy.
Latest:
Cost Impact of Switching From Metoprolol to Nebivolol for HypertensionA large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.
Latest:
A Linezolid Prior Authorization Program: Clinical and Economic OutcomesThis study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Latest:
Podcasts Deliver Information and News to Pharmacists, Students, and TechniciansIn a continuing quest to be a one-stop shop to pharmacy professionals and students, Pharmacy Times® has upped its game on the podcast front in 2021 and will continue to introduce more podcasts in 2022.
Latest:
COPD Medication Adherence and Persistence Among Managed Medicare EnrolleesThe authors evaluated the significance of Medicare prescription plan choice on chronic obstructive pulmonary disease maintenance medication adherence and persistence using Optum Research Database information.
Latest:
Wrapping Up an Exciting Year for PharmacyFrom a mega-pharmacy benefit merger to pharmacy robberies to a blockbuster drug going off patent, 2011 was a landmark year for the field of pharmacy.
Latest:
Effectiveness of Ezetimibe Monotherapy in Patients With HypercholesterolemiaThe effectiveness of ezetimibe monotherapy for lowering low-density lipoprotein cholesterol was assessed in a managed care population.
Latest:
Studies Demonstrate the Power of PrEPSeveral large investigations have demonstrated the considerable efficacy of TDF/FTC taken daily or intermittently, reducing the risk of HIV acquisition by more than 95% in high-risk individuals.
Latest:
Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia InclusionEvidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.
Latest:
NASP: Specialty Medication Benefits Must be Thoroughly VettedSpecialty pharmacy is like the quarterback for care, seamlessly coordinating what happens with the patient, doctors, drugs, and pharmacy.
Latest:
Clinical Outcomes of Oral Anticancer Regimens in NSCLC Patients Managed in an Integrated Health-System Specialty Pharmacy ProgramPharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.
Latest:
USP : Are You Protecting Yourself?Pharmacists and interns who prepare HDs or work in areas where these drugs are located are potentially at risk for these adverse health effects. It is important for us to understand the risks and be proactive about protecting ourselves.
Latest:
New and Novel HIV MedicationsCombination antiretroviral therapy (ART) has greatly reduced HIV-associated morbidity and mortality and improved the quality of life for those living with HIV.
Latest:
The Expanding Role of the Specialty PharmacistCultivating a career in specialty pharmacy has never been more exciting.
Latest:
Promoting Brain Function Is Key Amid COVID-19 CrisisNecessary measures taken during the pandemic may exacerbate some underlying factors that can lead to decline.
Latest:
Pharmacists With Long-Term Disability: Common Issues That Can Jeopardize Your Financial SecurityThe financial consequences of becoming disabled can be devastating if pharmacists lack proper financial planning.
Latest:
Applying Value-Based Incentive Models Within Community Pharmacy PracticeHealthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.
Latest:
Outcomes of a Specialty Pharmacy Program for Oral Oncology MedicationsOur research focuses on the clinical and economic outcomes of patients receiving care from a payer-designated specialty pharmacy program compared with regular retail pharmacies.
Latest:
Effectiveness of Ezetimibe Monotherapy in Patients With HypercholesterolemiaThe effectiveness of ezetimibe monotherapy for lowering low-density lipoprotein cholesterol was assessed in a managed care population.
Latest:
What Are the Newest Breast Cancer Treatment Options?Cyclin-Dependent Kinase 4/6 Inhibitors, Margetuximab, Trastuzumab Deruxtecan, and Tyrosine Kinase Inhibitors Have Shown Promising Results
Latest:
Formulary Coverage for Antihypertensive Drugs Used in ChildrenDifferences in formulary coverage of antihypertensive medications for children between private and public insurance plans may impact physician prescribing practices and patient outcomes.
Latest:
Out-of-Pocket Healthcare Expenditures and Caps in Patients With Chronic ConditionsA small proportion of patients with chronic conditions have very high healthcare expenditures, and a trend was observed toward increasing coinsurance requirements.
Latest:
Importance of Patient Navigation in Specialty PharmacyMany patients face significant challenges in accessing their specialty medications, which highlights the importance of pharmacy-deployed patient navigation programs designed to help resolve nonclinical, system-related barriers to care.
Latest:
Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia SyndromeWhile fibromyalgia is associated with a small increase in healthcare costs compared with matched controls, chronic opioid use in these patients results in a large increase.
Latest:
Cost of Squamous Cell Cancer of the Head and NeckThe cost of squamous cell cancer of the head and neck is driven primarily by the end-of-life phase. Treatment costs increased following the approval of cetuximab.
